Literature DB >> 6291740

Krukenberg tumors of the ovary: a clinicopathologic analysis of 27 cases.

F Holtz, W R Hart.   

Abstract

A series of 27 typical Krukenberg tumors of the ovary were analyzed. By definition, all examples were characterized by the presence of mucinous signet-ring carcinoma cells within a cellular, nonneoplastic ovarian stroma. The patients' ages ranged from 20-70 years; almost one-half were 40 years of age or younger. A primary carcinoma of the stomach (16 cases) or colon (four cases) was found in 20 (90.9%) of 22 patients with available follow-up data. The primary gastrointestinal carcinomas had been diagnosed before emergence of the ovarian tumors in only five cases. The ovarian and gastrointestinal tumors were synchronously diagnosed in ten cases, while in five instances the primary carcinomas were not discovered until after the ovarian tumors had been treated. An acceptable primary extraovarian cancer was not detected in two women. Both had bilateral Krukenberg tumors and died with widespread carcinomatosis less than two years postoperatively. Typically, the ovarian tumors were bilateral, asymmetrically large and solid. Important histologic features included a greater abundance of intracellular neutral glycoproteins than acidic mucins, a storiform pattern of hyperplastic cortical stromal cells (44.4%) and carcinomatous emboli (51.6%). While the entity of "primary" Krukenberg tumor cannot be unequivocally denied, all women with typical Krukenberg tumors should be considered as having metastatic carcinoma, usually from the stomach, until proven otherwise.

Entities:  

Mesh:

Year:  1982        PMID: 6291740     DOI: 10.1002/1097-0142(19821201)50:11<2438::aid-cncr2820501132>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Metastatic gastric cancer to the female genital tract.

Authors:  Hiroshi Matsushita; Kazushi Watanabe; Akihiko Wakatsuki
Journal:  Mol Clin Oncol       Date:  2016-09-21

2.  Sclerosing stromal tumor of the ovary. A hormonal, histochemical and ultrastructural study.

Authors:  G Martinelli; E Govoni; S Pileri; F W Grigioni; C Doglioni; G Pelusi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

Review 3.  Pelvic incidentalomas.

Authors:  R M Gore; G M Newmark; K H Thakrar; U K Mehta; J W Berlin
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

4.  Multimodality imaging of ovarian cystic lesions: Review with an imaging based algorithmic approach.

Authors:  Ashish P Wasnik; Christine O Menias; Joel F Platt; Usha R Lalchandani; Deepak G Bedi; Khaled M Elsayes
Journal:  World J Radiol       Date:  2013-03-28

5.  Sonographic appearance of Krukenberg tumor from gastric carcinoma.

Authors:  B I Choi; I W Choo; M C Han; C W Kim
Journal:  Gastrointest Radiol       Date:  1988

6.  Bilateral ovarian metastasis from distal common bile duct carcinoma developing after choledochal cyst excision.

Authors:  Seung Eun Lee; Yoo Shin Choi; Mi Kyung Kim; Hyoung-Chul Oh; Jae Hyuk Do
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2015-05-31

7.  Exophthalmos Revealing a Krukenberg Tumor: A Case Presentation and Review of the Literature.

Authors:  Mohamed Fetohi; Sanaa Errarhay; Aziz Bazine; Tarikq Namad
Journal:  Case Rep Oncol       Date:  2016-07-29

8.  An ovarian mass after breast cancer: Metachronous carcinoma or metastasis? A case report.

Authors:  Georgios-Marios Makris; Alexandros Marinelis; Marco-Johannes Battista; Charalampos Chrelias; Nikolaos Papantoniou
Journal:  Int J Surg Case Rep       Date:  2016-12-30

9.  Risk factors for appendiceal involvement in women with epithelial ovarian cancer.

Authors:  Mustafa Erkan Sarı; Elmas Korkmaz; Murat Öz; Tayfun Güngör; Mehmet Mutlu Meydanlı
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-05-11

10.  Ovarian metastases from primary gastrointestinal malignancies: the Royal Marsden Hospital experience and implications for adjuvant treatment.

Authors:  A E Taylor; V M Nicolson; D Cunningham
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.